不发酵糖革兰阴性杆菌的分布和耐药性分析 |
| |
引用本文: | 王凌燕,;朱光发,;王爱萍. 不发酵糖革兰阴性杆菌的分布和耐药性分析[J]. 中国感染与化疗杂志, 2014, 0(4): 305-309 |
| |
作者姓名: | 王凌燕, 朱光发, 王爱萍 |
| |
作者单位: | [1]首都医科大学附属北京安贞医院感染科,北京100029; [2]首都医科大学附属北京安贞医院检验科,北京100029 |
| |
摘 要: | 目的了解北京安贞医院2008--2012年不发酵糖革兰阴性杆菌的临床分布和耐药情况。方法采用VITEK—compact系统和Phoenix 100系统进行细菌鉴定,稀释法进行体外抗菌药物敏感试验。结果临床分离不发酵糖革兰阴性杆菌2450株。其中鲍曼不动杆菌1401株(57.2%),铜绿假单胞菌625株(25.5%),嗜麦芽窄食单胞菌246株(10.0%)。标本来源依次为呼吸道(80.9%)、血液(8.1%)和伤口分泌物(3.9%)。科室分布依次为重症监护室(50.0%)、心脏外科(17.0%)和呼吸内科(11.5%)。药敏试验结果显示,2008--2012年鲍曼不动杆菌对亚胺培南的耐药率分别为62.3%、79.2%、70.4%、76.1%和67.8%;铜绿假单胞菌对亚胺培南的耐药率分别为28.7%、25.0%、27.6%、31.1%和32.0%;嗜麦芽窄食单胞菌对甲氧苄啶-磺胺甲口恶唑和左氧氟沙星敏感率最高。结论由于不发酵糖革兰阴性杆菌有较高的耐药性,治疗时应根据药敏试验结果合理选用抗菌药物。
|
关 键 词: | 不发酵糖革兰阴性杆菌 医院感染 抗菌药物 |
Distribution and antibiotic resistance profile of nonfermentative gram negative bacteria |
| |
Affiliation: | WANG Lingyan, ZHU Guangfa, Wang Aiping. (Department of Infectious Diseases, Anzhen Hospital, Capital Medical University, Beijing 100029, China) |
| |
Abstract: | Objective To investigate the clinical distribution and antibiotic resistance of the nonfermenting bacterial strains isolated in Beijing Anzhen Hospital from 2008 to 2012. Methods The bacteria were identified by VITEK-compact system and Phoenix 100 system. Antimicrobial susceptibiity was tested by dilution method. Results A total of 2 450 strains of nonfermentative gram-negative bacteria were isolated from clinical specimens. Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas rnaltophilia accounted for 57. 2%, 25.5% and 10.0%. Specimens were mostly collected from respiratory tract (80.9%), followed by blood (8.1%) and wound exudates (3.9%). The strains were mainly collectd from ICU (50.0%), cardiac surgery ward (17.0%) and respiratory medical ward (11.5%). The prevalence of imipenem- resistant A. baumannii was 62. 3%, 79. 2%, 70. 4%, 76. 1%, 67. 8% from 2008 to 2012. The prevalence of imipenem- resistant P. aeruginosa was 28. 7%, 25.0%, 27. 6%, 31. 1% and 32. 0%. S. rnaltophilia strains showed the highest susceptibility to trimethoprim-sulfamethoxazole and levofloxacin. Conclusions The high prevalence of antibiotic-resistant nonfermenting bacteria poses a great challenge to clinicins, The rational treatment choice should be based on the result of suseptibility testing. |
| |
Keywords: | non-fermenting bacterium nosocomial infection antibacterial agent |
本文献已被 维普 等数据库收录! |
|